First United Bank Trust Acquires 1,060 Shares of Abbott Laboratories (NYSE:ABT)

First United Bank Trust lifted its position in shares of Abbott Laboratories (NYSE:ABT) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,068 shares of the healthcare product maker’s stock after purchasing an additional 1,060 shares during the period. First United Bank Trust’s holdings in Abbott Laboratories were worth $1,451,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Independent Investors Inc. increased its position in Abbott Laboratories by 0.4% in the 4th quarter. Independent Investors Inc. now owns 52,750 shares of the healthcare product maker’s stock valued at $3,815,000 after buying an additional 200 shares in the last quarter. Blue Fin Capital Inc. boosted its stake in Abbott Laboratories by 1.1% during the 3rd quarter. Blue Fin Capital Inc. now owns 18,522 shares of the healthcare product maker’s stock valued at $1,359,000 after purchasing an additional 201 shares during the last quarter. Northside Capital Management LLC boosted its stake in Abbott Laboratories by 2.3% during the 4th quarter. Northside Capital Management LLC now owns 9,009 shares of the healthcare product maker’s stock valued at $652,000 after purchasing an additional 206 shares during the last quarter. United Capital Management of KS Inc. boosted its stake in Abbott Laboratories by 1.6% during the 4th quarter. United Capital Management of KS Inc. now owns 15,416 shares of the healthcare product maker’s stock valued at $1,115,000 after purchasing an additional 238 shares during the last quarter. Finally, JGP Wealth Management LLC boosted its stake in Abbott Laboratories by 0.5% during the 3rd quarter. JGP Wealth Management LLC now owns 46,474 shares of the healthcare product maker’s stock valued at $3,409,000 […]

Tags:

Click Here to Continue...


Add a Comment

Your email address will not be published. Required fields are marked *